LC said “ it has an opportunity to obliterate cancer types that have never been touched before”
” we’ve got multiple tumors types “
then she said “ even in this dose escalation stage we can open up many different indications with this therapeutics.”
In investor lngueage. We should be looking at several more breakthrough therapies designations.
They are trialling cancers that NO therapeutics have touched before. We might end up with multiple indications similar to Bile Duct cancer. Imagine 5 more Breat through designations needing only 10 Pax per designation. In the other video she talks about expanding the trials.
Certainly looks like a big year.
Sounds
Media Thread, page-12183
-
- There are more pages in this discussion • 2,483 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |